SFL.NS
Sheela Foam Limited [SFL.NS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
SFL.NS Stock Summary
Top SFL.NS Correlated Resources
SFL.NS
Top 10 Correlated ETFs
SFL.NS
Top 10 Correlated Stocks
SFL.NS
SFL.NS Financial details
Company Rating
Strong Buy
Market Cap
128.36B
Income
2.11B
Revenue
30.96B
Book val./share
208.77
Cash/share
60.04
Dividend
-
Dividend %
-
Employees
2.78K
Optionable
No
Shortable
Yes
Earnings
31 Jan 2023
P/E
60.62
Forward P/E
40.93
PEG
-64.27
P/S
4.11
P/B
8.52
P/C
43.44
P/FCF
-638.64
Quick Ratio
0.55
Current Ratio
1.84
Debt / Equity
0.23
LT Debt / Equity
0.23
-
-
EPS (TTM)
44.13
EPS next Y
63.73
EPS next Q
-
EPS this Y
-8.59%
EPS next Y
44.4%
EPS next 5Y
72.49%
EPS last 5Y
10.2%
Revenue last 5Y
8.72%
Revenue Q/Q
-0.95%
EPS Q/Q
26.13%
-
-
-
-
SMA20
-7.51%
SMA50
-12.5%
SMA100
-0.34%
Inst Own
-
Inst Trans
-
ROA
9%
ROE
16%
ROC
0.12%
Gross Margin
38%
Oper. Margin
7%
Profit Margin
7%
Payout
-
Shs Outstand
48.78M
Shs Float
13.08M
-
-
-
-
Target Price
-
52W Range
2535.95-4055.0
52W High
-35.68%
52W Low
+2.89%
RSI
37
Rel Volume
0.37
Avg Volume
13.76K
Volume
5.05K
Perf Week
-2.77%
Perf Month
-3.21%
Perf Quarter
-7.05%
Perf Half Y
-9.62%
-
-
-
-
Beta
0.339726
-
-
Volatility
16.36%, 90.42%
Prev Close
0.46%
Price
2608.35
Change
-0.37%
SFL.NS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-03-31
| Metric | History | 2018-03-31 | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 |
|---|---|---|---|---|---|---|
| Revenue per share | 402.5 | 438.52 | 445.12 | 498.9 | 611.24 | |
| Net income per share | 27.41 | 27.42 | 39.65 | 48.73 | 44.55 | |
| Operating cash flow per share | 27.41 | 28.26 | 33.52 | 53.36 | 40.42 | |
| Free cash flow per share | 8.73 | 17.44 | -4.08 | 40.09 | 6.91 | |
| Cash per share | 44.86 | 58.85 | 54.11 | 33.75 | 32.16 | |
| Book value per share | 122.43 | 149.66 | 188.54 | 242.77 | 285.46 | |
| Tangible book value per share | 120.75 | 147.99 | 141.55 | 190.67 | 287.03 | |
| Share holders equity per share | 122.43 | 149.66 | 188.54 | 242.77 | 285.46 | |
| Interest debt per share | 11.34 | 7.95 | 66.02 | 74.8 | 99.1 | |
| Market cap | 73.27B | 65.8B | 71.56B | 99.36B | 171.59B | |
| Enterprise value | 72.23B | 65.94B | 74.22B | 102.27B | 175.85B | |
| P/E ratio | 54.8 | 49.2 | 37 | 41.8 | 78.96 | |
| Price to sales ratio | 3.73 | 3.08 | 3.3 | 4.08 | 5.75 | |
| POCF ratio | 54.8 | 47.73 | 43.76 | 38.17 | 87.03 | |
| PFCF ratio | 172.08 | 77.33 | -359.51 | 50.81 | 509.18 | |
| P/B Ratio | 12.27 | 9.01 | 7.78 | 8.39 | 12.32 | |
| PTB ratio | 12.27 | 9.01 | 7.78 | 8.39 | 12.32 | |
| EV to sales | 3.68 | 3.08 | 3.42 | 4.2 | 5.9 | |
| Enterprise value over EBITDA | 30.59 | 27.8 | 22.74 | 24.94 | 44.78 | |
| EV to operating cash flow | 54.02 | 47.83 | 45.39 | 39.29 | 89.19 | |
| EV to free cash flow | 169.64 | 77.49 | -372.88 | 52.3 | 521.81 | |
| Earnings yield | 0.02 | 0.02 | 0.03 | 0.02 | 0.01 | |
| Free cash flow yield | 0.01 | 0.01 | 0 | 0.02 | 0 | |
| Debt to equity | 0.01 | 0.01 | 0.26 | 0.2 | 0.24 | |
| Debt to assets | 0.43 | 0.37 | 0.44 | 0.43 | 0.41 | |
| Net debt to EBITDA | -0.44 | 0.06 | 0.81 | 0.71 | 1.08 | |
| Current ratio | 1.62 | 2 | 1.97 | 1.55 | 1.47 | |
| Interest coverage | 25.11 | 21.37 | 20.82 | 18.82 | 13.8 | |
| Income quality | 1 | 1.03 | 0.85 | 1.09 | 0.91 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0.02 | |
| Sales general and administrative to revenue | 0 | 0 | 0.01 | 0.01 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.01 | 0.01 | 0.14 | 0.13 | 0 | |
| Capex to operating cash flow | -0.68 | -0.38 | -1.12 | -0.25 | -0.83 | |
| Capex to revenue | -0.05 | -0.02 | -0.08 | -0.03 | -0.05 | |
| Capex to depreciation | -2.59 | -1.34 | -3.11 | -0.89 | -2.02 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 274.78 | 303.84 | 410.13 | 515.93 | 534.9 | |
| ROIC | 0.27 | 0.21 | 0.2 | 0.19 | 0.13 | |
| Return on tangible assets | 0.13 | 0.12 | 0.14 | 0.13 | 0.09 | |
| Graham Net | -28.76 | -10.46 | -70.99 | -114.87 | -134.91 | |
| Working capital | 2.27B | 3.44B | 3.72B | 2.96B | 2.63B | |
| Tangible asset value | 5.89B | 7.22B | 6.91B | 9.3B | 0 | |
| Net current asset value | 1.47B | 2.54B | 331.69M | -448.4M | -1.51B | |
| Invested capital | 0.08 | 0.04 | 0.34 | 0.29 | 0.33 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 1.98B | 1.86B | 1.98B | 2.3B | 2.65B | |
| Average inventory | 2.44B | 2.51B | 2.71B | 3.15B | 3.15B | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 51.66 | 41.4 | 51.66 | 58.27 | 57.74 | |
| Days of inventory on hand | 53.61 | 54.1 | 70.46 | 80.01 | 60.26 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 7.07 | 8.82 | 7.07 | 6.26 | 6.32 | |
| Inventory turnover | 6.81 | 6.75 | 5.18 | 4.56 | 6.06 | |
| ROE | 0.22 | 0.18 | 0.21 | 0.2 | 0.16 | |
| Capex per share | -18.68 | -10.82 | -37.6 | -13.27 | -33.51 |
Quarterly Fundamentals Overview
Last date of statement is 2020-09-30 for Q2
| Metric | History | 2018-09-30 | 2019-03-31 | 2019-09-30 | 2020-03-31 | 2020-09-30 |
|---|---|---|---|---|---|---|
| Revenue per share | 109.73 | 109.16 | 101.93 | 102.89 | 124.6 | |
| Net income per share | 4.99 | 7.76 | 12.04 | 6.5 | 14.14 | |
| Operating cash flow per share | -5.66 | 7.07 | 0.61 | 8.38 | 8.38 | |
| Free cash flow per share | -13.06 | 4.36 | -5.15 | -1.02 | -1.02 | |
| Cash per share | 18.73 | 58.85 | 2.57 | 54.11 | 60.04 | |
| Book value per share | 134.65 | 149.66 | 168.97 | 188.54 | 208.77 | |
| Tangible book value per share | 213.98 | 147.99 | 240.49 | 141.55 | 160.17 | |
| Share holders equity per share | 134.65 | 149.66 | 168.97 | 188.54 | 208.77 | |
| Interest debt per share | 6.93 | 6.48 | 5.89 | 64.44 | 59.35 | |
| Market cap | 81.55B | 63.51B | 62.9B | 62.73B | 64.72B | |
| Enterprise value | 80.99B | 63.64B | 63.09B | 65.39B | 67.08B | |
| P/E ratio | 334.76 | 41.93 | 107.08 | 49.49 | 23.46 | |
| Price to sales ratio | 15.23 | 11.93 | 12.65 | 12.5 | 10.65 | |
| POCF ratio | -295.14 | 184.25 | 2.1K | 153.43 | 158.3 | |
| PFCF ratio | -127.98 | 298.52 | -250.2 | -1.26K | -1.3K | |
| P/B Ratio | 12.41 | 8.7 | 7.63 | 6.82 | 6.35 | |
| PTB ratio | 12.41 | 8.7 | 7.63 | 6.82 | 6.35 | |
| EV to sales | 15.13 | 11.95 | 12.69 | 13.03 | 11.04 | |
| Enterprise value over EBITDA | 153.57 | 101.83 | 72.86 | 108.49 | 59.78 | |
| EV to operating cash flow | -293.14 | 184.64 | 2.1K | 159.94 | 164.08 | |
| EV to free cash flow | -127.11 | 299.16 | -250.94 | -1.31K | -1.35K | |
| Earnings yield | 0 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Free cash flow yield | -0.01 | 0 | 0 | 0 | 0 | |
| Debt to equity | 0.6 | 0.01 | 0.43 | 0.26 | 0.23 | |
| Debt to assets | 0.38 | 0.37 | 0.3 | 0.44 | 0.43 | |
| Net debt to EBITDA | -1.05 | 0.22 | 0.21 | 4.41 | 2.11 | |
| Current ratio | 1.86 | 2 | 2.73 | 1.97 | 1.74 | |
| Interest coverage | -15.64 | 48.49 | -28.33 | 12.66 | 20.9 | |
| Income quality | -1.13 | 0.91 | 0.05 | 1.29 | 0.59 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.14 | 0.14 | |
| Capex to operating cash flow | 0.77 | -0.38 | -0.11 | -1.12 | -1.12 | |
| Capex to revenue | -14.84 | -0.02 | -17.67 | -0.09 | -0.08 | |
| Capex to depreciation | -0.53 | -1.34 | -0.71 | -3.11 | -3.11 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 122.98 | 161.66 | 213.95 | 166 | 257.7 | |
| ROIC | 0.05 | 0.06 | 0.08 | 0.04 | 0.07 | |
| Return on tangible assets | 0.02 | 0.03 | 0.05 | 0.02 | 0.04 | |
| Graham Net | -0.1 | -10.46 | 41.91 | -70.99 | -81.57 | |
| Working capital | 2.63B | 3.44B | 4.65B | 3.72B | 3.33B | |
| Tangible asset value | 6.49B | 7.22B | 8.16B | 6.91B | 7.81B | |
| Net current asset value | 1.75B | 2.54B | 3.77B | 331.69M | -65.4M | |
| Invested capital | 0 | 0.04 | 0 | 0.34 | 0.28 | |
| Average receivables | 1.74B | 0 | 1.74B | 0 | 0 | |
| Average payables | 1.24B | 2.22B | 1.15B | 2.34B | 2.39B | |
| Average inventory | 1.98B | 2.51B | 2.06B | 2.71B | 2.57B | |
| Days sales outstanding | 29.06 | 0 | 31.56 | 0 | 0 | |
| Days payables outstanding | 36.89 | 44.23 | 39.02 | 54.99 | 48.89 | |
| Days of inventory on hand | 52.43 | 57.8 | 69.96 | 75 | 55.16 | |
| Receivables turnover | 3.1 | 0 | 2.85 | 0 | 0 | |
| Payables turnover | 2.44 | 2.03 | 2.31 | 1.64 | 1.84 | |
| Inventory turnover | 1.72 | 1.56 | 1.29 | 1.2 | 1.63 | |
| ROE | 0.04 | 0.05 | 0.07 | 0.03 | 0.07 | |
| Capex per share | -7.4 | -2.7 | -5.77 | -9.4 | -9.4 |
SFL.NS Frequently Asked Questions
What is Sheela Foam Limited stock symbol ?
Sheela Foam Limited is a IN stock , located in Ghaziabad of Uttar pradesh and trading under the symbol SFL.NS
What is Sheela Foam Limited stock quote today ?
Sheela Foam Limited stock price is $2608.35 today.
Is Sheela Foam Limited stock public?
Yes, Sheela Foam Limited is a publicly traded company.
Company Profile
- Volume Average 13.76K
- Market Capitalization 128.36B
- Employee 2.78K
- CEO Mr. Frank Van Gogh
- Headquarters Ghaziabad,UTTAR PRADESH,IN
- IPO Date 2016-12-09
-
Website
https://www.sheelafoam.com 
Sheela Foam Limited engages in the manufacture and sale of polyurethane foams primarily in India and internationally. The company provides various technical products, such as automotive, reticulated, ultraviolet stable, and silenctech foam products. It also offers mattresses, furniture cushioning, pillows, bolsters, sofa-cum-beds, comforters/blankets, mattress protectors, and other products. The company provides its products under the Sleepwell, Feather Foam, and Starlite brands. It distributes its products through distributors, dealers, and multi-brand outlets. The company also exports its products to approximately 25 countries worldwide. Sheela Foam Limited was incorporated in 1971 and is headquartered in Noida, India.
